Latest Stock Buy or Sell? Make More Informed Decisions!

The inventor and world's largest producer of foamed plastic and aluminum composites. They have superior material strength to weight ratios. They are made from recycled materials and are themselves recyclable. They have an excellent balance sheet and can make acquisitions. They recently grew at about 10%. (Analysts’ target: CHF 1,210.00).

They make drug ingredients. They take a drug from the development stage through to the production stage on behalf of a biotech or pharma company. They are a global low cost producer and own some of the enabling technology. (Analysts’ target: CHF 345.93).

It's been hammered because of this lawsuit and report by a short-seller. Normally this would be a buy based on valuation. There's a tiny chance that MFC will lose this case. That said, he'll wait for the decision before buying this. The judgement may pass in late-2018 or early-2019.

He's long owned it and it's a major holding. All the FANGs have been hit lately. Google's last report beat, but their revenues were light. It went down today because of the general sell-off and a possible UK digital tax is rearing its head. The markets are overreacting now. Google has 21x earnings for 2019, so it's still reasonable. Now, is a great entry point.

This sector has been caught up in euphoria. Peers are now breaking below their 200-day moving averages, which is not a good sign. This sector is very, very overvalued though it has a lot of potential. Cannabis is like the internet crash of the late-1900's. Same thing. There will be an industry, but you can't pick out the winners and losers at today's valuations.

Pays a fair 6.5% dividend yield. Things are as bleak as they can be in Canadian oil. FRU is generating enough cash to pay their dividend. Don't buy more or enter it. Hold.

Canadian banks: All are 10-15% off their highs and have broken below their 200-day moving averages. If you're long-term, you'll get paid a decent dividend to wait. Eventually the big 5 banks will come back. Good P/E's. You can buy them now for the long term. He prefers TD for its U.S. exposure, and the weak Canadian dollar. The banks could fall another 5% along with this market. Nobody knows.

(Past Top Pick Nov. 30, 2017, Up 7%) He still own this and will talk about it later (in the show).

They've had a rough few days after reporting last week. They're starting to report earnings regularly, so investors can now put multiples on them. Their 56x 2019 earnings are too rich for him. It's trading at 19x book. A great company and will do very well across different ventures. Still too pricey for him, but it's getting reasonable.

A very defensive stock with great products and brand, but little earnings growth, not enough for him. Pays a good dividend yield and the company won't go out of business. It will weather this downturn. He prefers Gilead.

Has long owned it and likes it. They had some bad years when they overpriced their hepatitis C drug and received bad press. They also sell HIV and heart drugs, sectors that are growing. They increased their guidance last week, a rarity these days. At 10x earnings, he'd buy it, not sell it. One overhang is that their CEO is leaving.

The crash of their 737 in Indonesia hit the stock today. Stay low and wait--see what the aviation findings are. If it turns out that their aircraft are in trouble, this stock will fall further.

This is a tremendous growth \opportunity as they expand internationally more. He watches it. They can raise their rates by $1 per month and easily raise revenues, yetd nobody will unsubscribe. But their multiple is way too high at 108x forward earnings.

The best-performing energy stock a year ago, but in July they announced they'd sell their Colombian developmen properties and distributing the cash to shareholders. It's a successful exploration company. They had been generating so much cash flow from their Colombian success that they felt they were being penalized for it, because they couldn't reinvest that cash fast enough. The market took it very negatively. Plus, their August earnings announced a dry well, and triggered more selling. Now, it's one of the worst energy performers. That said, since August they've had two successful well announcements that nobody noticed. Sometimes the market acts irrationally on a stock like this one. Trading at 3.2x cash flow. (Analysts' price target $31.08)

This is a security blanket in times of volatility. A big, long-time holding for him. Big product and earnings announcements this week. There could be another positive surprise coming. The analysts underestimate the new phones--they could have a good impact on the bottom line. (1.4% dividend, $237.59 price target)